Currently holds positions in IHS Markit Ltd and BlackRock Inc
Position | Company | Period |
---|---|---|
Independent Director | IHS Markit Ltd | Jan. 1, 2010 - |
Independent Director | BlackRock Inc | March 15, 2018 - |
Independent Member of the Supervisory Board | Axel Springer SE | Aug. 29, 2016 - April 18, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-04-18 | 2022-04-18 |
BlackRock Inc
(BLK)
|
B Purchase |
2,000
+15.5%
681.441,362,880 USD |
2,000 +15.5% | 681.44 | 1,362,880 USD | |
2022-04-18 | 2022-04-14 |
BlackRock Inc
(BLK)
|
B Purchase |
1,000
+8.4%
701.00701,000 USD |
1,000 +8.4% | 701.00 | 701,000 USD | |
2020-06-22 | 2020-06-18 |
Royalty Pharma PLC
(RPRX)
|
B Purchase |
1,500,000
+inf%
28.0042,000,000 USD |
1,500,000 +inf% | 28.00 | 42,000,000 USD | |
2020-04-01 | 2020-04-01 |
IHS Markit Ltd
(INFO)
|
B Purchase |
483
+1.1%
57.5027,773 USD |
483 +1.1% | 57.50 | 27,773 USD | |
2020-04-01 | 2020-03-31 |
IHS Markit Ltd
(INFO)
|
B Purchase |
2,500
+5.9%
59.48148,700 USD |
2,500 +5.9% | 59.48 | 148,700 USD | |
2020-03-30 | 2020-03-26 |
IHS Markit Ltd
(INFO)
|
B Purchase |
20,000
+88.2%
58.461,169,200 USD |
20,000 +88.2% | 58.46 | 1,169,200 USD |